Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 10;44(3-4):e10310.
doi: 10.1002/sim.10310.

Improving the Effectiveness of Sample Size Re-Estimation: An Operating Characteristic Focused, Hybrid Frequentist-Bayesian Approach

Affiliations

Improving the Effectiveness of Sample Size Re-Estimation: An Operating Characteristic Focused, Hybrid Frequentist-Bayesian Approach

Ping Gao. Stat Med. .

Abstract

Sample size re-estimation (SSR) is perhaps the most used adaptive procedure in both frequentist and Bayesian adaptive designs for clinical trials. The primary focus of all current frequentist and Bayesian SSR procedures is type I error control. We propose a hybrid frequentist-Bayesian SSR approach that focuses on optimizing operating characteristics (OC), which uses simulations to investigate the associated OC and adjusts accordingly. The hybrid approach incorporates the Bayesian predictive power into the frequentist framework of SSR. Simulations show that the hybrid approach can substantially outperform popular frequentist type error-focused SSR procedure. The hybrid approach can substantially improve the effectiveness of SSR using Bayesian predictive power.

Keywords: Bayesian; conditional power; hybrid adaptive design; modified predictive power; predictive power; sample size re‐estimation.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Comparison of CP^, PP, MPP, and CI_MPP curves.
FIGURE 2
FIGURE 2
Comparing CP^, PP, and CPθ at the planned sample size.
FIGURE 3
FIGURE 3
Comparing CP^, PP, and CPθ at Nmax.
FIGURE 4
FIGURE 4
New sample size comparison.

Similar articles

References

    1. Berry D. A., “Interim Analyses in Clinical Trials: Classical vs Bayesian Approaches,” Statistics in Medicine 4 (1985): 521–526. - PubMed
    1. Bauer P., “Multistage Testing With Adaptive Designs,” Biometrie Und Informatik in Medizin Und Biologie 20 (1989): 130–148.
    1. Proschan M. A. and Hunsberger S. A., “Designed Extension of Studies Based on Conditional Power,” Biometrics 51, no. 4 (1995): 1315–1324. - PubMed
    1. Müller H. H. and Schäfer H., “Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches,” Biometrics 57 (2001): 886–891. - PubMed
    1. Lee J. J. and Liu D. D., “A Predictive Probability Design for Phase II cancer Clinical Trials,” Clinical Trials 5, no. 2 (2008): 93–106. - PMC - PubMed

LinkOut - more resources